Allogeneic thymus induced pluripotent stem cell

Tolerance Bio focuses on enhancing health span by targeting the thymus, which plays a crucial role in regulating immune tolerance. The company aims to preserve, restore, and manipulate thymic function to develop therapies for immune-mediated diseases. By leveraging the thymus's regulatory capabilities, Tolerance Bio seeks to create innovative treatments that can improve immune responses and overall health.

The company's pipeline includes advanced thymus-based therapies designed to address various immune-related conditions. Through their research and development efforts, Tolerance Bio is committed to pioneering solutions that not only treat existing diseases but also promote long-term immune health. Their approach underscores the importance of the thymus in maintaining immune balance and offers a promising avenue for therapeutic intervention in immune-mediated disorders.

United States

Tolerance Bio will increase health span by preserving and restoring the function of the thymus, the master regulator of immune tolerance. Immune-mediated diseases represent a significant unmet medical challenge: cancer, autoimmunity, transplant rejection, infections, immune deficiencies, and allergies.

Tolerance Bio

Company Details